Colin Sandercock

Colin Sandercock

Corporate Officer/Principal at CUE BIOPHARMA, INC.

Net worth: 18 021 $ as of 29/06/2026

69 year
Commercial Services
Consumer Services
Health Technology

Profile

Colin G.
Sandercock
is Senior Vice President-Intellectual Property at Cue Biopharma, Inc. since 2026, with employment at the firm starting in 2017.
Formerly, Mr. Sandercock was Partner at Perkins Coie LLP from 2009 to 2017, Co-Chairman-Life Science Practice Group at Proskauer Rose LLP from 2006 to 2009, Co-Chairman-Intellectual Property Practice Group at Heller Ehrman LLP from 2000 to 2006, and Chairman-Chemical Practice Group at Foley & Lardner LLP from 1990 to 2000.
Education includes graduate degrees from the University of Pennsylvania in 1980 and The Catholic University of America in 1984, and an undergraduate degree from Moravian College in 1978.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/05/2026 571 ( 0.01% ) 18 021 $ 29/06/2026

Colin Sandercock active positions

CompaniesPositionStart
CUE BIOPHARMA, INC. Corporate Officer/Principal 31/05/2026

Former positions of Colin Sandercock

CompaniesPositionEnd
Corporate Officer/Principal 31/10/2017
Corporate Officer/Principal 30/06/2009
Corporate Officer/Principal 31/12/2005
Corporate Officer/Principal 31/12/1999
See the detail of Colin Sandercock's experience

Training of Colin Sandercock

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Colin Sandercock